1-7 of 7
Ling Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199

Beatrice T. Wang, Tasnim Kothambawala, Ling Wang, Thomas J. Matthew, Susan E. Calhoun, Avneesh K. Saini, Maya F. Kotturi, Genevive Hernandez, Eric W. Humke, Marvin S. Peterson, Angus M. Sinclair, Bruce A. Keyt
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12): 2483–2494.
https://doi.org/10.1158/1535-7163.MCT-20-1132
Published: 01 December 2021
View article titled, Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199
Open the PDF for Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199 in another window
Includes: Supplementary data
Journal Articles

Abstract B071: Detecting ultra low-frequency variants and fusions using a novel amplicon-based Accu-CometTM method

Ling Wang, Grace Q. Zhao, Li Weng, Xiao Chen, Min Li, Xue Yang, Jun Zhao, Hongyan Wang, Kang Ying, Malek Faham, Shengrong Lin, Jiatao Lou
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): B071.
https://doi.org/10.1158/1535-7163.TARG-17-B071
Published: 01 January 2018
View article titled, Abstract B071: Detecting ultra low-frequency variants and fusions using a novel amplicon-based Accu-Comet<sup>TM</sup> method
Journal Articles

Abstract B26: Phase 1b trial of investigational NEDD8-activating enzyme (NAE) inhibitor pevonedistat (TAK-924/MLN4924) in combination with docetaxel, paclitaxel/carboplatin, or gemcitabine in patients (pts) with solid tumors

A. Craig Lockhart, Todd M. Bauer, R. Donald Harvey, Carrie B. Lee, Charu Aggarwal, Roger B. Cohen, Farhad Sedarati, Ling Wang, Hélène M. Faessel, Bruce J. Dezube, Sergio Santillana, Afshin Dowlati
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B26.
https://doi.org/10.1158/1535-7163.TARG-15-B26
Published: 01 December 2015
View article titled, Abstract B26: Phase 1b trial of investigational NEDD8-activating enzyme (NAE) inhibitor pevonedistat (TAK-924/MLN4924) in combination with docetaxel, paclitaxel/carboplatin, or gemcitabine in patients (pts) with solid tumors
Journal Articles

Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer

Ling Wang, Adam J. Mosel, Gregory G. Oakley, Aimin Peng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (11): 2401–2409.
https://doi.org/10.1158/1535-7163.MCT-12-0448
Published: 08 November 2012
View article titled, Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer
Open the PDF for Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer in another window
Journal Articles

Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody

Angela Coxon, James Bready, Hosung Min, Stephen Kaufman, Juan Leal, Dongyin Yu, Tani Ann Lee, Ji-Rong Sun, Juan Estrada, Brad Bolon, James McCabe, Ling Wang, Karen Rex, Sean Caenepeel, Paul Hughes, David Cordover, Haejin Kim, Seog Joon Han, Mark L. Michaels, Eric Hsu, Grant Shimamoto, Russell Cattley, Eunju Hurh, Linh Nguyen, Shao Xiong Wang, Anthony Ndifor, Isaac J. Hayward, Beverly L. Falcón, Donald M. McDonald, Luke Li, Tom Boone, Richard Kendall, Robert Radinsky, Jonathan D. Oliner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (10): 2641–2651.
https://doi.org/10.1158/1535-7163.MCT-10-0213
Published: 10 October 2010
View article titled, Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody
Open the PDF for Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody in another window
Includes: Supplementary data
Journal Articles

Challenge and promise: roles for Livin in progression and therapy of cancer

Ling Wang, Qi Zhang, Bin Liu, Mei Han, Baoen Shan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (12): 3661–3669.
https://doi.org/10.1158/1535-7163.MCT-08-0480
Published: 15 December 2008
View article titled, Challenge and promise: roles for Livin in progression and therapy of cancer
Open the PDF for Challenge and promise: roles for Livin in progression and therapy of cancer in another window
Journal Articles

Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma–associated herpesvirus

Tamara K. Nun, David J. Kroll, Nicholas H. Oberlies, Djaja D. Soejarto, Ryan J. Case, Pius Piskaut, Teatulohi Matainaho, Chelsey Hilscher, Ling Wang, Dirk P. Dittmer, Shou-Jian Gao, Blossom Damania
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (8): 2360–2370.
https://doi.org/10.1158/1535-7163.MCT-07-0108
Published: 15 August 2007
View article titled, Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma–associated herpesvirus
Open the PDF for Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma–associated herpesvirus in another window